A
Atossa Therapeutics (ATOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which th... Read more
- USD0.75
- USD0.80
- USD0.73
- USD1.66
- -13.50%
- --
- 691.08k
- 739.90k
- 105M
- 0.55
- -40.20%
Stock News
5 hours ago
CD Projekt: AI Catalyst Poised To Slash Development Cycles And Boost Margins
SeekingAlpha
6 hours ago
Inflation Has Bottomed
SeekingAlpha
8 hours ago
Needing Dollars, Iran-Backed Militias Turn to Visa and Mastercard
Yahoo
8 hours ago
Wendy's: Downgrade To Sell On Weak Earnings In The Near-Term
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
